AMDA

Angie Szumlinski
|
July 7, 2021
AMDA’s Statement on Aducanumab Approval

Angie Szumlinski
|
May 18, 2021
Emotional and Behavioral Needs – Younger Residents

Angie Szumlinski
|
January 14, 2021
Opportunity to Purchase PPE at Bulk Pricing Rates

Angie Szumlinski
|
December 7, 2020
Delay Antibody Treatment in Nursing Homes
Stay informed with Angie’s expert perspective on current clinical challenges, industry trends, and real-world risk insights.
